Actinium Pharmaceuticals
ATNM
#9930
Rank
NZ$62 M
Marketcap
NZ$1.99
Share price
-1.64%
Change (1 day)
-5.22%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -NZ$64.79 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.09 Million. In 2024 the company made an earning of -NZ$69.77 Million, an increase over its 2023 earnings that were of -NZ$86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$64.79 Million-7.14%
2024 -NZ$69.77 Million-18.87%
2023 -NZ$86 Million52.24%
2022 -NZ$56.49 Million36.61%
2021 -NZ$41.35 Million11.48%
2020 -NZ$37.09 Million1.46%
2019 -NZ$36.56 Million-7.37%
2018 -NZ$39.47 Million-11.46%
2017 -NZ$44.58 Million10.67%
2016 -NZ$40.28 Million15.7%
2015 -NZ$34.82 Million-14.86%
2014 -NZ$40.89 Million129.19%
2013 -NZ$17.85 Million-8.55%
2012 -NZ$19.51 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$61.6 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.25 M-113.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.12 B-1,919.25%๐Ÿ‡บ๐Ÿ‡ธ USA